IBD-associated colorectal cancer ‘differs from sporadic CRC’

Among 31 IBD patients studied, no tumours were of the epithelial type, researchers report
Reuters Health
DNA

Colorectal cancers (CRC) that evolve from inflammatory bowel disease (IBD) are genetically distinct from sporadic CRC, a study shows.

The findings may be relevant to prognosis and, eventually, to treatment options, the investigators say.